IDT Stock Recent News

CORALVILLE, Iowa--(BUSINESS WIRE)-- #Amplicon--Advancing virology research: IDT's xGen™ HIV Amplicon Panel consisting of primers designed to cover 99.3% of the HIV genome is now available.

Discover why Zacks rates IDT Corporation as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore IDT's strong growth in high-margin segments and financial health amid market challenges.

CORALVILLE, Iowa--(BUSINESS WIRE)-- #AvianFlu--A new PCR/qPCR solution from IDT will support surveillance and monitoring of the current H5N1 strain of bird flu.

May same-store sales increased 4.7% year-over-year NEWARK, N.J., June 07, 2024 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for May 2024.

IDT's overall topline benefits from revenue growth in the majority of its segments.

IDT Corporation (NYSE:IDT ) Q3 2024 Earnings Conference Call June 5, 2024 5:30 PM ET Company Participants Shmuel Jonas - CEO Marcelo Fischer - CFO Conference Call Participants Operator Good evening, and welcome to the IDT Corporation's Third Quarter Fiscal Year 2024 Earnings Call. In today's presentation, IDT's management will discuss IDT's financial and operational results for the three month period ended April 30, 2024.

NRS: Recurring Revenue * Up 45%; Income from Operations Up 129%, Adjusted EBITDA ** Up 108% net2phone: Subscription Revenue * Up 17%; Income from Operations Up 226%; Adjusted EBITDA Up 107% BOSS Money: Transactions Up 44%; Revenue Up 42% -- Fintech Segment Adjusted EBITDA Turns Positive

Newark, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- BOSS Money , the remittance and payments brand of IDT Corporation (NYSE: IDT), today announced several significant initiatives to expand its popular money transfer service, including remittances within the United States.

CORALVILLE, Iowa--(BUSINESS WIRE)-- #AdvancesinSyntheticBiology--IDT's newly expanded U.S. manufacturing site provides a growth runway for manufacturing of synthetic biology products to support growing demand.

NEWARK, NJ, May 20, 2024 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications solutions, has scheduled its report of financial and operational results for the third quarter of its fiscal year 2024 (the three months ended April 30, 2024) on Wednesday, June 5, 2024.